ASX News Health Care Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to… Caroline Smith2 mins31 March 2025 11:30 (AEDT)
ASX News Health Care Monash tests show strong cardioprotective qualities for Algorae drug candidate Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168 Caroline Smith2 mins29 November 2024 10:43 (AEDT)
Contributors & Collaborations How to negotiate your future Negotiation is a vital skill no matter whether you’re an employee, business owner or investor. It’s… Andrew Baxter2 mins07 October 2024 12:25 (AEDT)